Atara Biotherapeutics, Inc
$9.71
-$0.40 (-3.96%)
$9.41Day Range$10.28
Key Statistics
Market Cap
$97.47M
Shares Outstanding
10.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 16, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$10.28
Day High
$10.28
Day Low
$9.41
Volume
26.4K
VWAP
$9.71
Prev Close
$10.11
Transactions
--
Acc. Volume
--
About Atara Biotherapeutics, Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283610 employees1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320805-623-4211IPO Oct 16, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001604464
- Composite FIGI
- BBG005Q3MQY4
- Share Class FIGI
- BBG005Q3MR36
- Ticker Root
- ATRA
- SIC Code
- 2836
About Atara Biotherapeutics, Inc (ATRA) Stock
Atara Biotherapeutics, Inc (ATRA) closed the 2026-09-17 session at $9.71, down 3.96% versus the previous close (-0.40). The stock opened at $10.28 and traded between $9.41 and $10.28 during that session. Session trading volume was 26K shares. The volume-weighted average price (VWAP) is $9.71.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Atara Biotherapeutics, Inc has a market capitalization of $97.5 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ATRA is listed on the XNAS exchange. The company employs approximately 10 people. Atara Biotherapeutics, Inc is headquartered in THOUSAND OAKS, CA. The recorded listing date is 2014-10-16.
On this page you can find market ATRA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.